<VariationArchive VariationID="462844" VariationName="NM_000083.3(CLCN1):c.434-2_434dup" VariationType="Duplication" Accession="VCV000462844" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-08" DateCreated="2018-05-26" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="457464" VariationID="462844">
      <GeneList>
        <Gene Symbol="CLCN1" FullName="chloride voltage-gated channel 1" GeneID="1180" HGNC_ID="HGNC:2019" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143316111" stop="143352083" display_start="143316111" display_stop="143352083" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="143013218" stop="143049096" display_start="143013218" display_stop="143049096" Strand="+" />
          </Location>
          <OMIM>118425</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000083.3(CLCN1):c.434-2_434dup</Name>
      <CanonicalSPDI>NC_000007.14:143321360:GCAGC:GCAGCAGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143321360" stop="143321361" display_start="143321360" display_stop="143321361" variantLength="3" positionVCF="143321360" referenceAlleleVCF="C" alternateAlleleVCF="CGCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="143018453" stop="143018454" display_start="143018453" display_stop="143018454" variantLength="3" positionVCF="143018453" referenceAlleleVCF="C" alternateAlleleVCF="CGCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.143018456_143018458dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.143018456_143018458dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.143321363_143321365dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.143321363_143321365dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009815.2" sequenceAccession="NG_009815" sequenceVersion="2" change="g.10238_10240dup">
            <Expression>NG_009815.2:g.10238_10240dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000083.3" sequenceAccession="NM_000083" sequenceVersion="3" change="c.434-2_434dup" MANESelect="true">
            <Expression>NM_000083.3:c.434-2_434dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000083.2" sequenceAccession="NM_000083" sequenceVersion="2" change="c.434-2_434dupAGC">
            <Expression>NM_000083.2:c.434-2_434dupAGC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000083.3" sequenceAccession="NM_000083" sequenceVersion="3" change="c.434_435insAGC" MANESelect="true">
            <Expression>NM_000083.3:c.434_435insAGC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000083.3" sequenceAccession="NM_000083" sequenceVersion="3" change="c.434-2_434dupAGC" MANESelect="true">
            <Expression>NM_000083.3:c.434-2_434dupAGC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4536952" DB="ClinGen" />
        <XRef Type="rs" ID="753470655" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000083.3(CLCN1):c.434-2_434dup AND multiple conditions" Accession="RCV000550058" Version="7">
        <ClassifiedConditionList TraitSetID="10487">
          <ClassifiedCondition DB="MedGen" ID="C2936781">Congenital myotonia, autosomal dominant form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751360">Congenital myotonia, autosomal recessive form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000083.3(CLCN1):c.434-2_434dup AND Congenital myotonia, autosomal recessive form" Accession="RCV002289753" Version="3">
        <ClassifiedConditionList TraitSetID="5755">
          <ClassifiedCondition DB="MedGen" ID="C0751360">Congenital myotonia, autosomal recessive form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-12-15" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000083.3(CLCN1):c.434-2_434dup AND not provided" Accession="RCV002473050" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-02-10" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-10" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-05-26" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(2); Uncertain significance(2)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">31544778</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34529042</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(2); Uncertain significance(2)</Comment>
        <DescriptionHistory Dated="2022-12-29">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10487" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3015" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal recessive form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+recessive/5074" DB="Genetic Alliance" />
                <XRef ID="20305008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker Generalized Myotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's disease</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="844" />
                <XRef ID="844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C0751360" DB="MedGen" />
              <XRef ID="MONDO:0009715" DB="MONDO" />
              <XRef Type="MIM" ID="255700" DB="OMIM" />
            </Trait>
            <Trait ID="5605" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal dominant form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+dominant/5073" DB="Genetic Alliance" />
                <XRef ID="57938005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen's disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">THD</ElementValue>
                <XRef Type="MIM" ID="160800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6176" />
                <XRef ID="6176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C2936781" DB="MedGen" />
              <XRef ID="MONDO:0008055" DB="MONDO" />
              <XRef Type="MIM" ID="160800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5755" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3015" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal recessive form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+recessive/5074" DB="Genetic Alliance" />
                <XRef ID="20305008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker Generalized Myotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's disease</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="844" />
                <XRef ID="844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C0751360" DB="MedGen" />
              <XRef ID="MONDO:0009715" DB="MONDO" />
              <XRef Type="MIM" ID="255700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5042929" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000083.3:c.434_435insAGC|OMIM:255700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581038" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000083.3:c.434_435insAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255700" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PM3, PM4, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5419037" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="A17411|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002771104" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31544778</ID>
          </Citation>
          <Comment>The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). In our internal patient population, this variant is statistically more frequent than in the general population, which is weak evidence this variant may be disease causing. This variant has been seen heterozygous and compound heterozygous in at least one individual with clinical features associated with this gene. This variant is also referred to as c.434-5_434-4insGCA in published literature. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. Computational tools yielded predictions that this variant is unlikely to have an effect on normal RNA splicing.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000083.2:c.434-2_434dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7136468" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="466ead9718831e676fee4f3be4f64e2bafbee8bfa044c1afdebdbfb8f5c21d60|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003830732" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000083.3:c.434-2_434dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7918495" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_000083.3:c.434-2_434dupAGC|MedGen:C0751360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004241525" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">34529042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31544778</ID>
          </Citation>
          <Comment>Variant summary: CLCN1 c.434-2_434dupAGC is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Two predict the variant weakens a 3 acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 2.4e-05 in 251114 control chromosomes. c.434-2_434dupAGC has been reported in the literature in individuals affected with Myotonia congenita. These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31544778, 34529042). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (likely pathogenic n=2, VUS n=2). Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000083.3:c.434-2_434dupAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751360" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14175850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1228830" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="734401|MedGen:C0751360;C2936781" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000636331" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31544778</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31544778</ID>
          </Citation>
          <Comment>This variant, c.434-2_434dup, results in the insertion of 1 amino acid(s) of the CLCN1 protein (p.Ala145dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs753470655, gnomAD 0.007%). This variant has been observed in individual(s) with clinical features of autosomal recessive myotonia congenita (PMID: 31544778; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant has been reported in individual(s) with autosomal dominant myotonia congenita (PMID: 31544778); however, the role of the variant in this condition is currently unclear. This variant is also known as c.434-5_434-4insGCA. ClinVar contains an entry for this variant (Variation ID: 462844). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.143018453_143018454insGCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751360" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2936781" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1228830" TraitType="Disease" MappingType="XRef" MappingValue="C0751360" MappingRef="MedGen">
        <MedGen CUI="C0751360" Name="Congenital myotonia, autosomal recessive form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7918495" TraitType="Disease" MappingType="XRef" MappingValue="C0751360" MappingRef="MedGen">
        <MedGen CUI="C0751360" Name="Congenital myotonia, autosomal recessive form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7136468" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5042929" TraitType="Disease" MappingType="XRef" MappingValue="255700" MappingRef="OMIM">
        <MedGen CUI="C0751360" Name="Congenital myotonia, autosomal recessive form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5419037" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1228830" TraitType="Disease" MappingType="XRef" MappingValue="C2936781" MappingRef="MedGen">
        <MedGen CUI="C2936781" Name="Congenital myotonia, autosomal dominant form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

